UPDATE: Todos Medical Reports Fourth-Quarter and Full-Year 2

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

Related Keywords

Greece , Germany , New York , United States , Leipzig , Sachsen , Georgia , Alpharetta , Israel , Tel Aviv , Rehovot , Hamerkaz , Eric Ribner , Daniel Hirsch , Geralde Commissiong , Billy Blanks , Provista Diagnosticsin , Pharma Ltd , Testing Lab , Exchange Commission , Cl Pharma Ltd , Todos Medical Ltd , University Of Leipzig , Provista Diagnostics Inc , National Stock Exchange , Todos Medical , Provista Diagnostics , Tollovir Phase , Tollovid Daily , Tollovid Maximum Strength , President Biden , Key Assets , Intellectual Property , Positive Primary , Secondary Endpoints Met , Oral Antiviral , Inhibitor Tollovir , Blinded Clinical Trial , Trial Results , Continue Growth , Lympro Alzheimer , National Stock , Fourth Quarter , Covid Testing , Corona Diagnostics , Provista Labs , Balance Sheet Items , New York City , Todos Biochemical Infrared Analyses , Lymphocyte Proliferation Test , Lympro Test , Corporate Contact , Investor Relations Contact , Sci Advisors , Coronavirus Pandemic , Technology , Science , Business , Health , Breast Cancer , Newmediawire , Cancer , Middle East ,